The trademark application MORPHOSYS was filed by MorphoSys AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 6, 2022, and it was registered by office on October 13, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1675788 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals
Active chemical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products
Antibodies sold as a component ingredient of pharmaceuticals
Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines.
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways
Pharmaceutical preparations for epigenetic modulators as therapeutics
Pharmaceuticals comprising small molecules
Small molecule compounds for medical use and drug delivery
Small molecule pharmaceuticals for the treatment of diseases and conditions
Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders
Diagnostic preparations for medical purposes
Biological substances for human medical diagnostics and analysis
Clinical medical reagents
Biological preparations for medical purposes
Pharmaceutical and veterinary preparations, agents and substances.
The mark was filed in class 42 with following description of goods:
Research and development of pharmaceutical preparations, medicines and vaccines
Providing medical and scientific research information
Conducting clinical trials
Scientific and technological services and research and design services.